Company / EPS (Diluted)
AbbVie EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.72
FY2025
5-year range
$2.72 / $6.63
FY2021-FY2025
Trend
-59.0%
vs FY2024
Sector context
#15 of 204
Health Care
What the data says
Among 204 Health Care companies, AbbVie is in the top 7% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $1.10 in FY2016 to $6.63 in FY2024.
Based on SEC 10-K filings.
2.72 in FY2025 with a 5-year CAGR of -5.8%. Top quartile in the Health Care sector.
Declined from $6.45 to $2.72 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 204This company $2.72 Sector average -$1.03
▼
+363.6% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 59.0% year-over-year.
- Ranks #15 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.72 | -59.0% |
| FY2024 | $6.63 | +2.8% |
| FY2023 | $6.45 | +137.1% |
| FY2022 | $2.72 | -48.5% |
| FY2021 | $5.28 | +44.3% |
| FY2020 | $3.66 | +10.9% |
| FY2019 | $3.30 | -9.1% |
| FY2018 | $3.63 | +16.0% |
| FY2017 | $3.13 | +184.5% |
| FY2016 | $1.10 | -57.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026